149 related articles for article (PubMed ID: 31395750)
1. Increasing the perceived relevance of cervical screening in older women who do not plan to attend screening.
Marlow LAV; Ryan M; Waller J
Sex Transm Infect; 2020 Feb; 96(1):20-25. PubMed ID: 31395750
[TBL] [Abstract][Full Text] [Related]
2. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
[TBL] [Abstract][Full Text] [Related]
3. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
4. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
McCaffery K; Irwig L
J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
[TBL] [Abstract][Full Text] [Related]
5. Characteristics Associated with HPV Diagnosis and Perceived Risk for Cervical Cancer Among Unmarried, Sexually Active College Women.
Wilson KL; Cowart CJ; Rosen BL; Pulczinski JC; Solari KD; Ory MG; Smith ML
J Cancer Educ; 2018 Apr; 33(2):404-416. PubMed ID: 27896666
[TBL] [Abstract][Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
7. Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval.
Ogilvie GS; Smith LW; van Niekerk D; Khurshed F; Pedersen HN; Taylor D; Thomson K; Greene SB; Babich SM; Franco EL; Coldman AJ
BMC Public Health; 2016 Mar; 16():213. PubMed ID: 26935960
[TBL] [Abstract][Full Text] [Related]
8. How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study.
Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
BMC Public Health; 2016 Aug; 15():708. PubMed ID: 27488178
[TBL] [Abstract][Full Text] [Related]
9. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
10. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
11. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
12. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.
McCaffery K; Waller J; Forrest S; Cadman L; Szarewski A; Wardle J
BJOG; 2004 Dec; 111(12):1437-43. PubMed ID: 15663132
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
14. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
15. Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.
Jayasinghe Y; Rangiah C; Gorelik A; Ogilvie G; Wark JD; Hartley S; Garland SM
J Clin Virol; 2016 Mar; 76 Suppl 1():S74-S80. PubMed ID: 26589584
[TBL] [Abstract][Full Text] [Related]
16. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
McBride E; Marlow L; Forster AS; Moss S; Myles J; Kitchener H; Patnick J; Waller J
BMJ Open; 2016 Dec; 6(12):e014356. PubMed ID: 28011816
[TBL] [Abstract][Full Text] [Related]
17. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
[TBL] [Abstract][Full Text] [Related]
20. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
